Wholesale of pharmaceutical and medical goods
RAYONEX BIOMEDICAL NORWAY AS
Revenue 2025
NOK 702,000
Operating profit
NOK 95,000
Equity
NOK 285,000
Incorporated
2016
Share capital
NOK 30,000
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2025 | Trend |
|---|---|---|
| Total operating revenue | 702k | |
| Total operating costs | 608k | |
| Operating profit (EBIT) | 95k | |
| Net financial items | 330 | |
| Profit for the year | 100k |
Balance sheet
| Post | 2025 | Trend |
|---|---|---|
| Total assets | 349k | |
| of which current assets | 137k | |
| Equity | 285k | |
| Total liabilities | 64k |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.